» Articles » PMID: 12678499

Neuropeptide Y: the Universal Soldier

Overview
Publisher Springer
Specialty Biology
Date 2003 Apr 8
PMID 12678499
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

The peptidic neuropeptide Y (NPY) has received great attention because it has been implicated in the regulation of several organ systems. In particular, NPY is involved in the regulatory loops that control food intake in the hypothalamus and appears also to be important for regulating the activity of neuroendocrine axes under poor metabolic conditions. Furthermore, NPY exerts vasoconstrictive action on the vasculature and potentiates the actions of many other vasoconstrictors. In addition, it was demonstrated to have trophic properties and could therefore contribute to cardiovascular remodeling. These various effects plus a number of others make NPY an attractive target for the potential treatment of human diseases, such as obesity, metabolic disorders, hypertension and heart failure.

Citing Articles

Neuropeptide Y in cancer-biological functions and potential clinical implications.

Sigorski D, Sejda A, Abualsaud N, Krawczyk E, Izycka-Swieszewska E, Kitlinska J Cancer Metastasis Rev. 2025; 44(1):21.

PMID: 39760953 PMC: 11703900. DOI: 10.1007/s10555-024-10237-z.


Topical Neuropeptide Y for Ischemic Skin Wounds.

Stangerup T, Gjerdrum L, Bzorek M, Andersen L, Heegaard A, Jorgensen L Int J Mol Sci. 2024; 25(6).

PMID: 38542321 PMC: 10970629. DOI: 10.3390/ijms25063346.


Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.

Sigorski D, Wesolowski W, Gruszecka A, Gulczynski J, Zielinski P, Misiukiewicz S J Cancer Res Clin Oncol. 2022; 149(9):5803-5822.

PMID: 36583743 PMC: 10356636. DOI: 10.1007/s00432-022-04540-x.


Current Insights Into the Role of Neuropeptide Y in Skin Physiology and Pathology.

Anderson Z, Dawson A, Slominski A, Harris M Front Endocrinol (Lausanne). 2022; 13:838434.

PMID: 35418942 PMC: 8996770. DOI: 10.3389/fendo.2022.838434.


Association of a Single-Nucleotide Variant rs11100494 of the Gene with Antipsychotic-Induced Metabolic Disorders.

Dobrodeeva V, Shnayder N, Novitsky M, Asadullin A, Vaiman E, Petrova M Pharmaceutics. 2022; 14(2).

PMID: 35213955 PMC: 8876767. DOI: 10.3390/pharmaceutics14020222.